Trace elements: role in the development of severe forms of COVID-19 and the possibility of correction

Abstract

The COVID-19 pandemic has set tasks for health professionals, in particular, related to the rapid diagnosis of the disease and the provision of medical care to patients with a new coronavirus infection. All over the world, scientific work is being carried out on the study of the clinical and epidemiological characteristics of the disease, the development of new means of its prevention and treatment. Epidemiological studies have identified a number of physiological and other factors that increase the risk of developing severe forms of the disease. Among them: old age, as well as concomitant diseases, including diabetes mellitus, cardiovascular diseases, chronic kidney disease and others. Changes in the balance of trace elements (ME) are considered as a risk factor for the development of severe forms of COVID-19. It is especially important that this factor can potentially be influenced, especially given the potential for replenishing the ME deficit in patients with COVID-19 for the purpose of early recovery and faster rehabilitation.

Keywords:coronavirus infection; epidemiological features; trace elements; preventive efficacy

Funding. The search and analytical work was carried out at the personal funds of the team of authors.

Conflict of interest. The authors of this article have confirmed that they have no conflicts of interest to report.

Contribution. All authors participated in concept development, literature analysis, article writing; prepared the first version of the manuscript – Sharipova M.M., Shimanovsky N.L.; critically reviewed and edited the manuscript – Romanov A.O., Arkhangelskaya A.N., Gurevich K.G., Popova I.A.; all authors read and approved the final version of the manuscript and agreed to submit it for publication.

For citation: Romanov А.О., Sharipova М.М., Popova I.A., Arkhangelskaia A.N., Gurevich K.G., Shimanovskiy N.L. Trace elements: role in the development of severe forms of COVID-19 and the possibility of correction. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (4): 91–8. DOI: https://doi.org/10.33029/2305-3496-2022-11-4-91-98

References

1.Richier Q., Plaçais L., Lacombe K., Hermine O. COVID-19: still a place for tocilizumab? Rev Med Interne. 2021; 42 (2): 73–8.

2. Rasmussen S., Sperling P., Poulsen M.S., et al. Medical students for health-care staff shortages during the COVID-19 pandemic. Lancet. 2020. Vol. 395. Р. 79–80.

3. Skalny A.V., Timashev P.S., Aschner M., et al. Serum zinc, copper, and other biometals are associated with COVID-19 severity markers. Metabolites. 2021; 11 (4): 244.

4.Velthuis A., Sjoerd H.E., Sims A., et al. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathogens. 2010; 6: e1001176.

5. Skalny A.V., Rink L., Ajsuvakova O.P., Aschner M., et al. Zinc and respiratory tract infections: Perspectives for COVID-19 (review). Int J Mol Med. 2020; 46: 17–26.

6. Zhao K., Huang J., Dai D., et al. Activation of transition metal oxides by in-situ electro-regulated structure-reconstruction for ultra-efficient oxygen evolution. Nano Energy. 2019; 58: 778–85.

7. Moghaddam A., Heller R.A., Sun. Q., et al. Selenium deficiency is associated with mortality risk from COVID-19. Nutrients. 2020; 12: 2098.

8. Zhou Х., Chen D., Wang L., et al. Polydopamine modified cyclodextrin polymer as efficient adsorbent for removing cationic dyes and Cu2+. J Hazard Mater. 2019; 389: 121897.

9. Hackler J., Heller R.A., Sun Q., Schwarzer M., et al. Relation of serum copper status to survival in COVID-19. Nutrients. 2021; 13 (6): 1898.

10. Majeed M., Nagabhushanam K., Gowda S., Mundkur L. An exploratory study of selenium status in healthy individuals and in patients with COVID-19 in a south Indian population: the case for adequate selenium status. Nutrition. 2021; 82: 111053.

11. Elcham A.S., Azam K., Azam J., Mostafa L., et al. Serum vitamin D, calcium, and zinc levels in patients with COVID-19. Clin Nutr ESPEN. 2021; 43: 276–82.

12. Vogel-Gongzales M., Talló-Parra M., Herrera-Fernández V., Pérez-Vilaró G., et al. Low zinc levels at admission associates with poor clinical outcomes in SARS-CoV-2 infection. Nutrients. 2021; 13 (2): 562.

13. Jothimani D., Kailasam E., Danielraj S., Nallathambi B., et al. COVID-19: poor outcomes in patients with zinc deficiency. Int J Infect Dis. 2020; 100: 343–9.

14. Im Jae Hyoung, et al. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020; 100: 390–3.

15. Zeng H.L., Zhang B., Wang X., Yang Q., Cheng L. Urinary trace elements in association with disease severity and outcome in patients with COVID-19. Environ Res. 2021; 194: 110670.

16. Lawaczeck R. COVID-19 and body iron: a survey on phenomenological and genetic correlations. ACS Chem Neurosci. 2020; 11 (24): 3996–4000.

17. Gonçalves T.J.M., Gonçalves S.E.A.B., Guarnieri A., Risegato R.C., et al. Association between low zinc levels and severity of acute respiratory distress syndrome by new coronavirus SARS-CoV-2. Nutr Clin Pract. 2021; 36 (1): 186–91.

18. Anuk А., Polat N., Akdas S., Erol S.A., et al. The relation between trace element status (zinc, copper, magnesium) and clinical outcomes in COVID-19 infection during pregnancy. Biol Trace Elem Res. 2021; 199 (10): 3608–17.

19. Zeng H.L., Yang Q., Yuan P., Wang X., Cheng L. Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19. FASEB J. 2021; 35 (3): e21392. DOI: https://doi.org/10.1096/fj.202002346RR

20. Ali N., Fariha K.A., Islam F., Mohanto N.C., et al. Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: a retrospective study in the Asian and European population. J Med Virol. 2021; 93 (7): 4326–33.

21. Yakubova L.V. The importance of compensation of micronutrient deficiencies in persons with cardiovascular diseases in the era OF COVID-19. Zhurnal Grodnenskogo gosudarstvennovo meditsinskogo universiteta [Journal of Grodno State Medical University]. 2020; 18 (6): 750–4. (in Russian)

22.Beketova H.V., Horiacheva I.P. Zinc and its impact on human health in conditions of COVID-19 pandemic: what’s new? Pediatriya. Vostochnaya Evropa [Pediatrics. Eastern Europe]. 2021; 9 (1): 8–20. (in Russian)

23.Laffaye G., Epishev V.V., Naumova K.A., Delafontaine A. How to prevent COVID-19 by means of a daily micronutrition protocol? An overview. Human. Sport. Medicine. 2020; 20 (4): 127–38.

24.Yakoob M.Y., Theodoratou E., et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria+. BMC Public Health. 2011; 11 (suppl 3): S23. URL: http://www.biomedcentral.com/1471-2458/11/S3/S23

25.Ashirmetov A.Kh., Mavlyanov I.R., Mavlyanov Z.I., Zharylkasynova G.Zh.COVID-19: Well-known drugs, new opportunities. Analiz riska zdorov’yu [Health Risks Analysis]. 2020; (4): 170–80. (in Russian)

26. Ezzati M., Lopez A.D., Rodgers A., Murray C.L.J. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization, 2004.

27. Gasmi A., Chirumbolo S., Peana M., Noor S., et al. The role of diet and supplementation of natural products in COVID-19 prevention. Biol Trace Elem Res. 2022; 200 (1): 27–30.

28. Subedi L., Tchen S., Gaire B.P., Hu B., Hu K. Adjunctive nutraceutical therapies for COVID-19. Int J Mol Sci. 2021; 22 (4): 1963.

29. Costagliola G., Spada E., Comberiati P., Peroni D. Could nutritional supplements act as therapeutic adjuvants in COVID-19? Ital J Pediatr. 2021; 47 (1): 32.

30. Mingazova E.N., Gureev S.A. Value of the micronutrient status of different social populations at infectious risks. Byulleten’ Natsional’nogo nauchno-issledovatel’skogo instituta obshchestvennogo zdorov’ya imeni N.A. Semashko [Bulletin of the National Research Institute of Public Health named after N.A. Semashko]. 2020; (3): 20–7. (in Russian)

31. Mel’nichenko G.A., Troshina E.A., Gerasimov G.A. Iodine deficiency disorders as a non-infectious epidemic: a look at the problem at the tome of COVID-19 pandemic. Terapevticheskiy arkhiv [Therapeutic Archive]. 2020; 92 (10): 4–8. (in Russian)

32. Kiselyov S.V., Belova E.V. Modern problems of food security and nutrition in Russia. Nauchnie issledovaniya ekonomicheskogo fakul’teta. Elektronniy zhurnal [Scientific Research of the Faculty of Economics. Electronic Journal]. 2020; 12 [1 (35)]: 70–91. (in Russian)

33.Batyrova G., Tlegenova Z., Kononets V., Umarova G., et al. Content of essential trace elements in the hair of residents of the Caspian Region of the Republic of Kazakhstan who recovered from COVID-19. Diagnostics (Basel). 2022; 12 (11): 2734. DOI: https://doi.org/10.3390/diagnostics12112734

34.Singh B., Singh S., Bhatia J.K., Kapoor R., Bhatia K. Role of matrix degradation, oxidative stress, inflammation & trace elements in COVID-19 patients: A multivariate study from India. Indian J Clin Biochem. 2022: 1–11. DOI: https://doi.org/10.1007/s12291-022-01059-3.

35.Evdokimova T.V., Korshun E.I., Silyutina M.V., Titareva L.V., Gorbunova E.O. Gerontological consultation online in the context of the COVID19 pandemic. Sovremennye problemy zdravookhraneniya i meditsinskoy statistiki [Modern Problems of Healthcare and Medical Statistics]. 2020; (4): 145–57. (in Russian)

36.Patel O., Chinni V., El-Khoury J., Perera M., et al. A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol. 2021; 93 (5): 3261–7.

37.Thomas S., Patel D., Bittel B., Wolski K., et al. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open. 2021; 4 (2): e210369.

38.Finzi E., Harrington A. Zinc treatment of outpatient COVID-19: a retrospective review of 28 consecutive patients. J Med Virol. 2021; 93 (5): 2588–90.

39.Kelleni M.T. Resveratrol-zinc nanoparticles or pterostilbene-zinc: potential COVID-19 mono and adjuvant therapy. Biomed Pharmacother. 2021; 139:

111626.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»